Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to $126000.0.

  • Firefly Neuroscience's Change in Accured Expenses rose 956.52% to $126000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$585000.0, marking a year-over-year decrease of 55348.84%. This contributed to the annual value of -$341000.0 for FY2024, which is 13256.92% down from last year.
  • Per Firefly Neuroscience's latest filing, its Change in Accured Expenses stood at $126000.0 for Q3 2025, which was up 956.52% from -$714000.0 recorded in Q2 2025.
  • Firefly Neuroscience's Change in Accured Expenses' 5-year high stood at $943000.0 during Q4 2023, with a 5-year trough of -$714000.0 in Q2 2025.
  • In the last 5 years, Firefly Neuroscience's Change in Accured Expenses had a median value of $20757.0 in 2023 and averaged $1716.0.
  • Per our database at Business Quant, Firefly Neuroscience's Change in Accured Expenses skyrocketed by 279336.57% in 2022 and then tumbled by 371684.26% in 2024.
  • Quarter analysis of 5 years shows Firefly Neuroscience's Change in Accured Expenses stood at $85941.0 in 2021, then crashed by 586.99% to -$418527.0 in 2022, then surged by 325.31% to $943000.0 in 2023, then plummeted by 49.84% to $473000.0 in 2024, then tumbled by 73.36% to $126000.0 in 2025.
  • Its Change in Accured Expenses was $126000.0 in Q3 2025, compared to -$714000.0 in Q2 2025 and -$470000.0 in Q1 2025.